And APE/AFE treatment reduced the level of the inflammatory mediators COX-2 and IL-6 in the AOM/DSS-induced CAC mouse model; the two are often elevated in humans or in AOM/DSS-induced CRC mice. The gene discussed is IL6; the disease is infectious otitis media.